Biologics finally move to first line in paediatric Crohn's

Paediatric patients with moderate to severe Crohn's disease can now access biologics in the first line, Senate Estimates was told, with the department expecting similar changes for ulcerative colitis to be finished by the end of the year as the PBAC Acting Chair admitted kids have been left behind for years.